2023 Annual Meeting | P10 - Poster Session 10

Date Wednesday 04/26/23

Time 08:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)

CME Available 0.00 CME credit

Event Timeline
08:00 AM - 09:00 AM EST	Abstract	9-001 - Characterizing EEG and Serum Biomarker Trends in Immune Effector Cell-Associated Neurotoxicity: A Case Series Andrew M. Nguyen, MD
08:00 AM - 09:00 AM EST	Abstract	9-002 - Algorithm to Annotate Epileptiform Abnormalities in EEG Reports Rachel S. Choi
08:00 AM - 09:00 AM EST	Abstract	9-003 - EEG patterns in Refractory Epilepsy with Focal Cortical Dysplasia and predictors of outcome after surgery Anuja R. Patil, MD, DM
08:00 AM - 09:00 AM EST	Abstract	9-004 - A simultaneous intracranial EEG- surface EMG analysis of generalized tonic-clonic seizures Aybuke Acar, MD
08:00 AM - 09:00 AM EST	Abstract	9-005 - Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device Pooja Venkatesh
08:00 AM - 09:00 AM EST	Abstract	9-006 - Automated Seizure Detection and Management using CERIBELL: A single center cohort study Ajay Rajshekar, DO
08:00 AM - 09:00 AM EST	Abstract	9-007 - Clarity Interpretation of Ceribell Rapid Response Electroencephalography Use Shows Limited Influence on Patient Disposition and Outcome Michael A. Connerney, MD
08:00 AM - 09:00 AM EST	Abstract	9-008 - The role of the perioperative use of EEG as a predictor/diagnostic tool for post-operative delirium: Systematic Review Maria J. Bruzzone, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	9-009 - Automated Detection of Central-positive Complexes & Postictal Generalized EEG Suppression in ECT-induced Seizures – An Illustrative Case Report Chetan Nayak, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	9-010 - Signs of Electro-cortical Disconnection revealed by Hd-EEG in Acute Stroke Patients: a Case Study. Elena Monai, MD
08:00 AM - 09:00 AM EST	Abstract	9-011 - EEG Analysis of Eye Movement Artifact in Parietal and Occipital Lobe Seizures: A Search for Epileptic Nystagmus Aybuke Acar, MD
08:00 AM - 09:00 AM EST	Abstract	9-012 - Temporal dynamics of triphasic waves and generalized periodic discharges George Plummer, MD
08:00 AM - 09:00 AM EST	Abstract	15-001 - The Role of Neurology Residency Programs Presence on Social Media During Residency Application Cleo Zarina A. Reyes, MD
08:00 AM - 09:00 AM EST	Abstract	15-002 - @NMatch2023: A Student-Led Social Media-Based Initiative to Guide Adult and Child Neurology Residency Applicants and Programs in a Digital Era Nupur N. Goel, MD
08:00 AM - 09:00 AM EST	Abstract	15-004 - Survey on the Fellowship Application Timeline for UCNS-accredited Behavioral Neurology and Neuropsychiatry Programs Sylvia Josephy, MD
08:00 AM - 09:00 AM EST	Abstract	15-005 - A Survey of Medical ��ɫ�� Pathways in Neurology Residency Programs Taha Qarni, MD
08:00 AM - 09:00 AM EST	Abstract	3-001 - Novel Pathways Correlating with MS-Related Tremor, A Case-Control Study Ahmed A. Bayoumi, MD
08:00 AM - 09:00 AM EST	Abstract	3-002 - Quantification of Thalamic Volume in Multiple Sclerosis: From the Multicenter INNI Dataset Towards the Clinical Application Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-003 - Third Ventricle Width is a Reliable and Clinically-Feasible Marker of Brain Atrophy in the Multiple Sclerosis Clinical Care Setting Sarah Levy, PhD
08:00 AM - 09:00 AM EST	Abstract	3-004 - Correspondence Among Gray Matter Damage and Neurotransmitter Maps Is Clinically Relevant in Multiple Sclerosis Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-005 - Myelin Density in Normal-Appearing White Matter in Measurements by q-Space Diffusional MRI Correlates with Clinical Disability in Multiple Sclerosis Haruhiko Motegi, MD
08:00 AM - 09:00 AM EST	Abstract	3-006 - Loss of gyrification is associated with disability progression in multiple sclerosis Jonadab Dos Santos Silva, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	3-007 - Gray Matter Microstructure Alterations in People with Multiple Sclerosis Based on Cell Body and Neurite Density Imaging Eva Angela Krijnen
08:00 AM - 09:00 AM EST	Abstract	3-008 - Functional Connectivity Modifications in Monoaminergic Circuits Occur in Fatigued MS Patients Treated With Fampridine and Amantadine Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-009 - Choroid Plexus Enlargement in Pediatric Multiple Sclerosis: Clinical Relevance and Effect of Sex Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-010 - The Insula Modulates the Effects of Aerobic Training on Cardiovascular Function and Ambulation in Multiple Sclerosis Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-011 - Progression independent of relapses in multiple sclerosis is associated with spinal cord and brain atrophy Kunio Nakamura, PhD
08:00 AM - 09:00 AM EST	Abstract	3-012 - Upper Cervical Cord Volume and Its Association with Brain Metrics in MS Nur Neyal, MD
08:00 AM - 09:00 AM EST	Abstract	3-013 - Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability Hussein Moussa, MD
08:00 AM - 09:00 AM EST	Abstract	3-014 - Time-Varying Functional Connectivity of the Hippocampus Is Associated With Cognitive Performance in Multiple Sclerosis Patients Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-015 - Radiomics-based Unsupervised Clustering of Acute Multiple Sclerosis Lesions Bastien C. Caba
08:00 AM - 09:00 AM EST	Abstract	3-016 - Choroid Plexus Enlargement In Systemic Lupus Erythematosus: Relationship With Auto-Antibody Status And Neuropsychiatric Involvement Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	3-017 - Myelin Water Fraction of Slowly Evolving Lesions is Associated With Disability in Multiple Sclerosis Shannon Kolind, PhD, MSc, BSc
08:00 AM - 09:00 AM EST	Abstract	3-018 - Longitudinal Changes of Functional Connectivity Dynamism Are Relevant for Disability Worsening in Multiple Sclerosis: A 2.5-Year Study Paolo Preziosa
08:00 AM - 09:00 AM EST	Abstract	12-002 - Reduced Frequencies of Post-Lumbar Puncture (LP) Headaches and Epidural Blood Patch Needs with Modifications of Standard LP Procedure Jay-Jiguang Zhu, MD, PhD, FAAN
08:00 AM - 09:00 AM EST	Abstract	12-003 - Idiopathic Intracranial Hypertension Causing Polyradiculopathy and Areflexia Anjali Kamath, MD
08:00 AM - 09:00 AM EST	Abstract	12-004 - Role of Obstructive Sleep Apnea in Idiopathic Intracranial Hypertension Mangayarkarasi Thandampallayam Ajjeya, MBBS
08:00 AM - 09:00 AM EST	Abstract	12-005 - Chiari I malformation: Clinical Characteristics, Symptoms, and Presentations. Yazan S. Al-Zamer
08:00 AM - 09:00 AM EST	Abstract	12-006 - The Queen Square Adult Leukodystrophy Group: 10 years-experience of a multidisciplinary diagnostic service Charles L. Wade, MBBS
08:00 AM - 09:00 AM EST	Abstract	12-007 - Five Creutzfeldt-Jakob Disease Cases Within One Year in Spectrum Health Hospitals in Grand Rapids, Michigan Jiangyong Min, MD
08:00 AM - 09:00 AM EST	Abstract	6-001 - Rapidly Progressive AIDP Secondary To Waldenström’s Macroglobulinemia, A Rare Cause With Fatal Respiratory Depression And Autonomic Instability Hongxuyang Yu, MD
08:00 AM - 09:00 AM EST	Abstract	6-002 - Guillain-Barré Syndrome Following Primary Cytomegalovirus Infection in a Patient with Liver Transplantation: a Case Report Jaime Toro, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-003 - A Curious Case of Cocaine-Induced Hypokalemic Periodic Paralysis Mimicking Guillain-Barre Syndrome Elizabeth G. Baumann, MD
08:00 AM - 09:00 AM EST	Abstract	6-005 - Ataxic variant of Guillain-Barre syndrome, with positive GD1b antibodies in an elderly male: a case report Camelia Valhuerdi Porto, MD
08:00 AM - 09:00 AM EST	Abstract	6-006 - Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies Kazim Jaffry
08:00 AM - 09:00 AM EST	Abstract	6-007 - Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies (SPIREA) Catherine Najem, PhD
08:00 AM - 09:00 AM EST	Abstract	6-008 - Preclinical Assessment of EPO-Derived Peptide JM4 in Experimental Autoimmune Neuritis Gabriel R. Arismendi, MD
08:00 AM - 09:00 AM EST	Abstract	6-010 - Ibrutinib in Anti-MAG Neuropathy with Waldenstrom Macroglobulinemia Zabeen K. Mahuwala, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-011 - Cellular and In Vivo Preclinical Pharmacodynamics and Pharmacology of Nipocalimab, an Anti-FcRn Blocking Therapeutic Antibody Leona Ling, PhD
08:00 AM - 09:00 AM EST	Abstract	6-012 - SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab Neda Sattarnezhad Oskouei, MD
08:00 AM - 09:00 AM EST	Abstract	6-013 - Intravenous Immunoglobulin Therapy for Autoimmune Dysautonomia in children: A Case Series Alexander Bolufer, MD
08:00 AM - 09:00 AM EST	Abstract	6-014 - Diagnosed in the Autoimmune Neurology Clinic: Two patients with different phenotypes of spinocerebellar ataxia type 27 Yoji Hoshina, MD
08:00 AM - 09:00 AM EST	Abstract	6-015 - Do Statins Have a Protective Effect Against Neuro-Autoimmune Disease and Comorbidity? Mohsen Ahmed
08:00 AM - 09:00 AM EST	Abstract	6-016 - Are Insulin Mimetics Protective Against Comorbidity in Patients With Neuro-Autoimmune Disease? Mohsen Ahmed
08:00 AM - 09:00 AM EST	Abstract	6-018 - Evidence of Neuroinflammation and Immunotherapy Responsiveness in Individuals with Down Syndrome Regression Disorder Jonathan Santoro, MD
08:00 AM - 09:00 AM EST	Abstract	6-019 - Machine learning-driven Interferon Signaling Gene Expression Score predicts Aicardi Goutières Syndrome Adeline Vanderver, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	6-020 - Recurrent Bickerstaff Encephalitis: Clinical Manifestation and Potential Treatment Options Ketevan Amirkhanashvili, MD
08:00 AM - 09:00 AM EST	Abstract	6-021 - Neuromyelitis Optica Spectrum Disorder (NMOSD) Relapse Triggered by Secondary Syphilis: A Case Report Luiza Lima, MD
08:00 AM - 09:00 AM EST	Abstract	6-022 - Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination, A case report and literature review. Srinivas Medavarapu, MD, MBBS
08:00 AM - 09:00 AM EST	Abstract	6-023 - COVID-19 Infection Linked to MOG Antibody-Associated Disease (MOGAD): Case Report Gira I. Graciano Mireles, MD
08:00 AM - 09:00 AM EST	Abstract	6-024 - Osmotic Demyelinating Syndrome Secondary to Breast Cancer Chemotherapy: a Case Report Jairo A. Gaitan Alfonso, MD
08:00 AM - 09:00 AM EST	Abstract	6-025 - A Tale of Two Cases: When to Use PLEX That is The Question Michael Grunstein, DO
08:00 AM - 09:00 AM EST	Abstract	6-026 - Cryoglobulinemia and Neuromyelitis optica: a case of progressive weakness and neurocognitive decline Aimalohi Esechie, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	6-027 - AMPA receptor antibody encephalitis in a patient with Myasthenia Gravis post thymectomy Samantha De Gannes, MD
08:00 AM - 09:00 AM EST	Abstract	6-029 - Isolated Brainstem Involvement and Low Titer MOG antibody as the Initial Presentation of MOG Antibody Disease Cynthia X. Wang, MD
08:00 AM - 09:00 AM EST	Abstract	6-031 - “Novel Psychiatric Manifestations of Anti-MOG Antibody Disease” Faiza Ahmed
08:00 AM - 09:00 AM EST	Abstract	7-001 - Cerebrospinal Fluid Neurofilament Light as a Marker of Neuro-axonal Injury in Normal Pressure Hydrocephalus Foad Taghdiri, MD, MSc
08:00 AM - 09:00 AM EST	Abstract	7-002 - Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases Briana Cameron, PhD
08:00 AM - 09:00 AM EST	Abstract	7-004 - Association Between Cerebrospinal Fluid Biomarkers of Amyloid and Tau and Neuropsychiatric Symptoms Among Participants from the National Alzheimer’s Coordinating Center Uniform Data Set Michael Walsh, Other
08:00 AM - 09:00 AM EST	Abstract	7-005 - Association of Alzheimer’s Plasma Biomarker Concentrations with Body Mass Index in Older Adults Serena S. Hoost, MD
08:00 AM - 09:00 AM EST	Abstract	7-006 - Identification of Plasma Biomarkers for Brain Endothelial Function Jenifer Cordon
08:00 AM - 09:00 AM EST	Abstract	7-008 - Assessment of Plasma Biomarkers by ImmunoMagnetic Reduction in Parkinson's Disease Dementia and Dementia with Lewy Bodies Giovanni R. Malaty, MD
08:00 AM - 09:00 AM EST	Abstract	7-009 - Influencing factors of plasma BACE1 and its relationship with plasma Aß: A cross-sectional study of a cognitively normal population of Shunyi cohort
08:00 AM - 09:00 AM EST	Abstract	7-010 - Plasma neurofilament light chain predicts Alzheimer’s pathology and progression of cognitive decline in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study Salvatore Mazzeo
08:00 AM - 09:00 AM EST	Abstract	1-001 - Reversible Splenial Lesion Syndrome (RESLES) in Sickle Cell Crisis Mimicking Marchiafava-Bignami Disease Yohannes S. Mulatu, MD
08:00 AM - 09:00 AM EST	Abstract	1-002 - An Unusual Case of Posterior Fossa Predominant Posterior Reversible Encephalopathy Syndrome (PRES) Leading to Acute Hydrocephalus Shalane A. Morales-Nunez, MD
08:00 AM - 09:00 AM EST	Abstract	1-003 - A Case of Brainstem Predominant PRES Jonathan Rosenthal, MD
08:00 AM - 09:00 AM EST	Abstract	1-004 - Cranial ultrasound image acquisition in a moving ambulance feasibility for pre-hospital EMS applications: A review of literature Benjamin Malinda
08:00 AM - 09:00 AM EST	Abstract	1-005 - Recurrent PRES after initiation of R-EPOCH & Methotrexate: A Case Study. Lauren Nelson, MD
08:00 AM - 09:00 AM EST	Abstract	1-006 - Severe Hypoglycemic Brain Injury Associated with Diffuse Restricted Diffusion on MRI Brain Sparing Cerebellar Lobes Estevao P. Ribeiro, MD
08:00 AM - 09:00 AM EST	Abstract	10-001 - Healthy astrocytes provide neuroprotection against apolipoprotein B-100-induced motor neuron degeneration Rose P. Griffin
08:00 AM - 09:00 AM EST	Abstract	10-002 - Bax inhibitor protects against apolipoprotein B-100-induced human motor neuron degeneration in vitro Ivy Gao
08:00 AM - 09:00 AM EST	Abstract	10-003 - Non-Invasive Mechanical Ventilation slows motor decline in Amyotrophic Lateral Sclerosis: a population-based study Maurizio Grassano, MD
08:00 AM - 09:00 AM EST	Abstract	10-004 - A large kindred with familial ALS due to the KIF5A p.Arg1007Lys mutation Jaroslaw Dulski, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	10-005 - Clinical and genetic characteristics associated with ALS diagnostic timeline: a population-based study Peter P. Pacut, MD
08:00 AM - 09:00 AM EST	Abstract	10-006 - Motor Nerve Conduction Slowing in Amyotrophic Lateral Sclerosis Kranthi K. Mandava
08:00 AM - 09:00 AM EST	Abstract	10-007 - Evaluation of Gastrointestinal Symptoms in an ALS Cohort Rizamarie Empeno, MD
08:00 AM - 09:00 AM EST	Abstract	10-008 - Long-term follow-up of five families from Turkey with UBQLN2 variants Hacer Durmus, MD
08:00 AM - 09:00 AM EST	Abstract	10-009 - At-Home Telespirometry (AHT) in Amyotrophic Lateral Sclerosis (ALS): Digital Health Technology and Quality Control Bhavya Narapureddy, MBBS
08:00 AM - 09:00 AM EST	Abstract	10-010 - C9orf72-related Familial Amyotrophic Lateral Sclerosis Manifesting as Monomelic Amyotrophy of the Lower Extremity Clover Youn, MD
08:00 AM - 09:00 AM EST	Abstract	10-011 - Analysis of Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Posted on www.clinicaltrials.gov from 1999-2022. Aaron Zelikovich, MD
08:00 AM - 09:00 AM EST	Abstract	10-012 - Real World Data as a control group, an ALS case study Matteo Locatelli, BS
08:00 AM - 09:00 AM EST	Abstract	10-013 - Association Between Amyotrophic Lateral Sclerosis Age at Diagnosis and Comorbid Conditions Mustafa Jaffry
08:00 AM - 09:00 AM EST	Abstract	10-014 - Small Molecule Modulators of Metabolic Dysfunction as a Therapeutic Strategy For ALS Daniel Kaganovich
08:00 AM - 09:00 AM EST	Abstract	10-015 - Parasympathetic cardiac dysfunction in Amyotrophic Lateral Sclerosis Cecilia Quarracino Benchetrit, MD
08:00 AM - 09:00 AM EST	Abstract	4-001 - Fetal Neurology Practice Survey Tomo Tarui, MD
08:00 AM - 09:00 AM EST	Abstract	4-002 - Relationship Between Maternal Antibodies to Fetal Brain and Prenatal Stress Exposure in Autism Spectrum Disorder David Q. Beversdorf, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	4-003 - Epilepsy surgery in a neonate: Resection of Right Temporal Neocortical Focal Cortical Dysplasia in a Three-Week-Old Infant. Prasanna Kumar Gangishetti, MBBS
08:00 AM - 09:00 AM EST	Abstract	4-005 - Microglia Maintain Homeostatic Conditions in the Developing Rostral Migratory Stream Sarah J. Meller, PhD
08:00 AM - 09:00 AM EST	Abstract	4-006 - Temporal Silencing of Purkinje Cell Neurotransmission Reveals a Dynamic Role for Cerebellar Function in Neurodevelopment Jason S. Gill, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	4-008 - Distinct Etiologies of RANBP2-negative Acute Necrotizing Encephalopathy of Childhood Vaishnavi L. Vaidyanathan, MD
08:00 AM - 09:00 AM EST	Abstract	4-009 - Longitudinal Assessment of High- and Low-Contrast Visual Acuity in Normally-Sighted Children John R. Sollee
08:00 AM - 09:00 AM EST	Abstract	4-010 - Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease Emily Sergio, Other
08:00 AM - 09:00 AM EST	Abstract	4-011 - Natural History of Seizures in Alexander Disease Kathryn Gallison, Other
08:00 AM - 09:00 AM EST	Abstract	4-012 - Top Caregiver Concerns for Individuals with the Ultra-Rare X-linked HNRNPH2-Related Neurodevelopmental Disorder Juliana Nitis
08:00 AM - 09:00 AM EST	Abstract	13-001 - Candida dubliniensis Meningitis in Immunocompetent Adults - case report and review of literature Lucas Horta, MD
08:00 AM - 09:00 AM EST	Abstract	13-002 - Neuroaspergillosis: Challenging Diagnosis and Management Stephen Jaworski, MD
08:00 AM - 09:00 AM EST	Abstract	13-003 - The Many Manifestations of Rhino-Orbital-Cerebral Mucormycosis: An Illustrative Case Report Megan E. Trenz, DO
08:00 AM - 09:00 AM EST	Abstract	13-004 - Invasive Optic Nerve Aspergillosis with Intracranial Extension in an Immunocompetent Patient Sukhraj Gill, MD
08:00 AM - 09:00 AM EST	Abstract	13-006 - Bilateral Disc Edema Heralding Ocular Syphilis: A Case Series Taylor R. Anderson, MD
08:00 AM - 09:00 AM EST	Abstract	13-007 - Neurosyphilis Presenting as Limbic Encephalitis: a Case Report Calvin Hu, MD
08:00 AM - 09:00 AM EST	Abstract	5-001 - Reducing the Receipt of Contraindicated Medications for Patients with Parkinson’s Disease Caroline Goldin, MD
08:00 AM - 09:00 AM EST	Abstract	5-002 - Community-Academic Initiative to Measure and Improve Underrepresented Group Participation in Parkinson's Disease Research Anabel Marre, Other
08:00 AM - 09:00 AM EST	Abstract	5-003 - Leveraging patient-reported outcomes to discern mobility trajectories in Parkinson’s disease Farren Briggs, PhD
08:00 AM - 09:00 AM EST	Abstract	5-004 - Functional Outcomes of an Intensive Multimodal Rehabilitation Intervention for Moderately Advanced Parkinson's Disease Priyanka Moondra, DO
08:00 AM - 09:00 AM EST	Abstract	5-005 - Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem? Sindhura Tadisetty
08:00 AM - 09:00 AM EST	Abstract	5-006 - Prioritizing Racial Representation in Treating People with Parkinson’s Disease: An Assessment of Racial Inclusion Among Parkinson’s Disease Clinical Trials between 1999-2022. Vivien Ikwuazom
08:00 AM - 09:00 AM EST	Abstract	5-007 - Neurologists’ Likelihood of Prescribing Injectable Parkinson’s disease (PD) Therapies Increases With ��ɫ�� on Patient Attitudes Rajeev Kumar, MD, FRCPC
08:00 AM - 09:00 AM EST	Abstract	5-008 - Continued usage of Parkinson's worsening drugs in patients diagnosed with Parkinson's disease – What can be done to solve this problem. Sindhura Tadisetty
08:00 AM - 09:00 AM EST	Abstract	5-009 - Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results Pavnit Kukreja, PharmD
08:00 AM - 09:00 AM EST	Abstract	5-010 - Improving Shared Decision-Making for Women with Parkinson’s Disease Michelle Fullard, MD
08:00 AM - 09:00 AM EST	Abstract	5-011 - Neurological Exam Findings Predictive of Falls in Patient’s with Parkinson’s Disease Allison R. Valerius, MD
08:00 AM - 09:00 AM EST	Abstract	5-012 - Clinical Utility of Home-to-Home Tele-neuropsychology (TeleNP) in the Assessment of Post-Operative Deep Brain Stimulation (DBS) Outcomes in Parkinson’s disease (PD) Patients Hannah M. Bullock
08:00 AM - 09:00 AM EST	Abstract	5-013 - Feasibility and Utility of Electrophysiology-Based DBS Programming in Clinical Practice. Dylan F. Del Papa, MD
08:00 AM - 09:00 AM EST	Abstract	5-014 - Assessment of Virtual Reality Devices as a Means of Objectively Monitoring Parkinson’s Disease Siegfried Hirczy, MD
08:00 AM - 09:00 AM EST	Abstract	5-015 - Characterizing Hospital Admissions in Persons with Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada Yasamin Mahjoub, MD
08:00 AM - 09:00 AM EST	Abstract	2-001 - Persistence to OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy Among Patients With Migraine: A Retrospective Cohort Study Seema Soni-Brahmbhatt
08:00 AM - 09:00 AM EST	Abstract	2-002 - Initiation of Fremanezumab Earlier in the Treatment Cycle may Result in Cost Savings to Payors in the United States
08:00 AM - 09:00 AM EST	Abstract	2-003 - Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients
08:00 AM - 09:00 AM EST	Abstract	2-004 - Real-world Adherence to Subsequent CGRP mAb Treatment Among Chronic Migraine (CM) Patients Initially Treated with OnabotulinumtoxinA: A Retrospective Claims Analysis Tae Jin Park
08:00 AM - 09:00 AM EST	Abstract	2-005 - Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine Elise R. Hennessy, MD
08:00 AM - 09:00 AM EST	Abstract	2-006 - Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the Open-Label Phase of the PERSIST Study Maurice Vincent, MD, PhD
08:00 AM - 09:00 AM EST	Abstract	2-007 - Adherence and Persistence among Patients with Migraine Initiating Concomitant Use of Self-Injectable Calcitonin Gene-related Peptide Monoclonal Antibody and Novel Acute Migraine Medications Oralee J. Varnado, PhD
08:00 AM - 09:00 AM EST	Abstract	2-008 - Beyond migraine headache day reduction: Clinically meaningful improvement in disability (MIDAS score) in the absence of greater than 50% reductions in monthly migraine days with galcanezumab Bert B. Vargas, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	2-009 - Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial Gary D. Berman, MD
08:00 AM - 09:00 AM EST	Abstract	2-010 - Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study Robert Croop, MD
08:00 AM - 09:00 AM EST	Abstract	2-011 - Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine Kathleen B. Mullin, MD
08:00 AM - 09:00 AM EST	Abstract	2-012 - Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors Stephanie J. Nahas, MD, FAAN
08:00 AM - 09:00 AM EST	Abstract	11-001 - Neurological Outcomes of Radiosurgery for Brain Metastases in the Motor Cortex Shefalika Prasad
08:00 AM - 09:00 AM EST	Abstract	11-002 - Peritumoral edema measurements provide additional information to RANO-BM based assessment of lung cancer brain metastases after Gamma Knife therapy Manpreet Kaur
08:00 AM - 09:00 AM EST	Abstract	11-003 - An Efficient Approach to Mapping the Distribution of Renal Cell Carcinoma (RCC) Brain Metastases (BrM) David O. Kamson, MD
08:00 AM - 09:00 AM EST	Abstract	11-004 - CNS-Isolated Blast Crisis in A Patient with Chronic Myeloid Leukemia on Dasatinib Benjamin J. Puccio, MD
08:00 AM - 09:00 AM EST	Abstract	11-005 - Missing the Mark: CSF CA 19-9 secures diagnosis of rare Pancreatic Leptomeningeal Carcinomatosis Sydnie Jones, MD
08:00 AM - 09:00 AM EST	Abstract	11-006 - Outcomes of Patients with Neoplastic Meningitis Undergoing Ventriculoperitoneal Shunting and Intrathecal Chemotherapy, A Single Institution Retrospective Review Amulya Gottiparthy, MD

Faculty Disclosures
Pavnit Kukreja, PharmD	Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Gular Mammadli, MD	Dr. Mammadli has nothing to disclose.
Koray Onuk	Koray Onuk has nothing to disclose.
	No disclosure on file
Anvita Potluri, MD	Dr. Potluri has nothing to disclose.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Yasmine Saad	No disclosure on file
Marshall Kirsch, DO	Dr. Kirsch has nothing to disclose.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Shruti P. Agnihotri, MD	An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Amaal J. Starling, MD, FAAN	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Andrea Harriott, MD	Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Anna Marisa Cervantes-Arslanian, MD, FAAN	Dr. Cervantes-Arslanian has nothing to disclose.
Mill Etienne, MD, MPH, FAAN	Dr. Etienne has nothing to disclose.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Mahouba Frih	MAHBOUBA FRIH has nothing to disclose.
Pilar Sanchez Alonso	Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for zambon. Pilar Sanchez Alonso has received personal compensation in the range of $0-$499 for serving as a Consultant for Bial. The institution of Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for zambon. Pilar Sanchez Alonso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for bial. Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie.
Tarek E. Ali, MBBS	Dr. Ali has nothing to disclose.
Samantha De Gannes, MD	Dr. De Gannes has nothing to disclose.
Teshamae Monteith, MD, FAAN	Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ�� with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Jinsy Andrews, MD, FAAN	Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
Stephanie J. Nahas, MD, FAAN	Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
George Plummer, MD	Dr. Plummer has nothing to disclose.
Monica E. Loghin, MD	Dr. Loghin has nothing to disclose.
James E. Siegler III, MD	Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Meredith Hatcher, PA	Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Shahin Hakimian, MD	Dr. Hakimian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. Dr. Hakimian has stock in Various.
Anna J. Tomczak, MSc	Miss Tomczak has nothing to disclose.
Jonathan Jagid	Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Antonio M. Omuro, MD, FAAN	Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
Sonika Agarwal, MD, FAAN	Dr. Agarwal has nothing to disclose.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Manpreet Kaur	Miss Kaur has nothing to disclose.
Aimalohi Esechie, MD, PhD	Dr. Esechie has nothing to disclose.
Lucas Horta, MD	Dr. Horta has nothing to disclose.
Megan E. Trenz, DO	Dr. Trenz has nothing to disclose.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
Victor Lami, MD	Dr. Eslami has nothing to disclose.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Dolly Reyes-Dumeyer	Dolly Reyes-Dumeyer has nothing to disclose.
Cristina Tassorelli	Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Organon. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Cristina Tassorelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva . The institution of Cristina Tassorelli has received research support from Abbvie.
Eric Anderson	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Jennifer A. Kim, MD	Dr. Kim has nothing to disclose.
Sarah B. Mulkey, MD, PhD	The institution of Dr. Mulkey has received research support from Thrasher Research Fund. The institution of Dr. Mulkey has received research support from Centers of Disease Control. The institution of Dr. Mulkey has received research support from National Institutes of Health.
Michael S. Rafii, MD, PhD	Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Nupur N. Goel, MD	Dr. Goel has nothing to disclose.
Simona V. Proteasa, MD	Dr. Proteasa has nothing to disclose.
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Badri Vardarajan	Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics.
Abu Nasar	No disclosure on file
Claire E. Delpirou Nouh, MD	The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Sukhraj Gill, MD	Dr. Gill has nothing to disclose.
Nelitza I. Rivera Vega, MD	Dr. Rivera Vega has nothing to disclose.
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Mark Milstein, MD, FAAN	Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities.
Zubair Ahmed, MD	Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Zain Guduru, MD, FAAN	Dr. Guduru has nothing to disclose.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from ��ɫ��.
Salvatore Mazzeo	Mr. Mazzeo has nothing to disclose.
Ramsey A. Falconer, MD, FAAN	Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Shalane A. Morales-Nunez, MD	Dr. Morales-Nunez has nothing to disclose.
Brooke Bloom, DO	Dr. McNeilly has nothing to disclose.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Catherine Najem, PhD	Dr. Najem has received personal compensation for serving as an employee of Janssen R&D US.
Lauren Orda-Nguyen, NP	Mrs. Orda-Nguyen has nothing to disclose.
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Jonathan H. Smith, MD	Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Marc R. Nuwer, MD, PhD, FAAN	Dr. Nuwer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Nuwer has received publishing royalties from a publication relating to health care.
Roy H. Hamilton, MD, MS, FANA, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Brian L. Appavu, MD	Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Nikki Win	Nikki Win has received personal compensation for serving as an employee of Genentech. Nikki Win has stock in Genentech .
Sarah J. Meller, PhD	Dr. Meller has received research support from National Institutes of Health Grant NIDCD F31DC018469-01.
Amaris Alayon, MD	Ms. Alayon has nothing to disclose.
Dan Matlock	No disclosure on file
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Joel Sullivan, DO	Dr. Sullivan has nothing to disclose.
John R. Sollee	Mr. Sollee has nothing to disclose.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Harry Zobel, Jr., DO	Dr. Zobel has nothing to disclose.
Shefalika Prasad	Ms. Prasad has nothing to disclose.
Corrado Bernasconi	Corrado Bernasconi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera.
Sudipa Biswas, MD	Dr. Biswas has nothing to disclose.
John T. Slevin, MD, FAAN	Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Colm Elliott	Colm Elliott has received personal compensation for serving as an employee of NeuroRx Research.
Rachel J. Saban, MD	Dr. Saban has nothing to disclose.
Tomo Tarui, MD	Dr. Tarui has nothing to disclose.
Anas A. Al-Khalili	Mr. Al-Khalili has nothing to disclose.
Giulia Giacomucci, MD	Ms. Giacomucci has nothing to disclose.
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Irene Vavasour, PhD	Dr. Vavasour has nothing to disclose.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Viviane T. Carvalho, MD	Dr. Carvalho has nothing to disclose.
Axel M. Baez-Lugo, MD	Dr. Baez-Lugo has nothing to disclose.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Patrizia Pantano	Patrizia Pantano has nothing to disclose.
Hussein Moussa, MD	Dr. Moussa has nothing to disclose.
Afaaq Ahmed	Mr. Ahmed has nothing to disclose.
Nico Paulo Dimal, MD	Dr. Dimal has nothing to disclose.
Mor Gueye	No disclosure on file
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Gira I. Graciano Mireles, MD	Dr. Graciano Mireles has nothing to disclose.
Sarah Doebley	Miss Doebley has nothing to disclose.
Sudhindra Vooturi, PT	Dr. Vooturi has nothing to disclose.
Rachel S. Choi	Ms. Choi has nothing to disclose.
Tara Tripathi Sarkar	No disclosure on file
Nicolò Tedone	Nicolò Tedone has nothing to disclose.
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Burcu Zeydan, MD	The institution of Dr. Zeydan has received research support from National Institutes of Health.
Ryan Kammeyer, MD	The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Timothy R. Smith, MD	The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Zahra Haghighat, MD	Dr. Haghighat has nothing to disclose.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
David O. Kamson, MD	The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund. The institution of Dr. Kamson has received research support from AACR. The institution of Dr. Kamson has received research support from Metavivor. The institution of Dr. Kamson has received research support from NIH.
Dongliang Wang	Dongliang Wang has nothing to disclose.
Anjali Kamath, MD	An immediate family member of Miss Kamath has received personal compensation for serving as an employee of Abbvie Pharmaceuticals. An immediate family member of Miss Kamath has received personal compensation for serving as an employee of Abbvie Pharmaceuticals. An immediate family member of Miss Kamath has stock in Biocryst Pharmaceuticals. An immediate family member of Miss Kamath has stock in Abbvie Pharmaceuticals.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Simrika Thapa, PhD	Dr. Thapa has nothing to disclose.
Christopher J. Whiting, DO	Dr. Whiting has nothing to disclose.
Loredana Storelli	Loredana Storelli has nothing to disclose.
Satoshi Kitagawa	No disclosure on file
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.
Leon Jekel	Mr. Jekel has nothing to disclose.
Rameez A. Merchant, MBBS	Dr. Merchant has nothing to disclose.
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Marina Sarno, Other	Dr. Sarno has nothing to disclose.
Srinath Ramaswamy, MD	Dr. Ramaswamy has nothing to disclose.
Masahiro Jinzaki	No disclosure on file
Lina Patel	No disclosure on file
Dana Klavansky, MD	Dr. Klavansky has nothing to disclose.
Shannon Kolind, PhD, MSc, BSc	Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Shravan Sivakumar, MBBS	Dr. Sivakumar has nothing to disclose.
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Gabriela T. Gomez	Ms. Gomez has nothing to disclose.
Michael Walsh, Other	Mr. Walsh has nothing to disclose.
Sarah Woidill	Sarah Woidill has nothing to disclose.
Hemani Ticku, MD	Dr. Ticku has nothing to disclose.
Lauren Gluck, MD	Dr. Gluck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeautics. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Rare Disease. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Heitor Cabral Frade, MD	Dr. Cabral Frade has nothing to disclose.
Puneet Uppal	No disclosure on file
Kazuko Hasegawa, MD	Dr. Hasegawa has nothing to disclose.
Ivy Gao	Miss Gao has nothing to disclose.
Laura J. Wu, MD, PhD	Dr. Wu has nothing to disclose.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Judith E. Warner, MD	Dr. Warner has received intellectual property interests from a discovery or technology relating to health care.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Holly A. Shill, MD, FAAN	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Wallace Brownlee, MD	Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Melissa Reider-Demer, DNP, MN, CNP	Dr. Reider-Demer has nothing to disclose.
Vaishnavi L. Vaidyanathan, MD	Dr. Vaidyanathan has nothing to disclose.
Aaron Zelikovich, MD	Dr. Zelikovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Yuyao Sun, MD	Dr. Sun has nothing to disclose.
Erin S. Beck, MD	Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.
Fenwick T. Nichols III, MD, FAAN	Dr. Nichols has nothing to disclose.
Nabeel Ahmed	Mr. Ahmed has nothing to disclose.
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Carlos Alva-Diaz	Carlos Alva-Diaz has nothing to disclose.
Ding-Ding Zhang	Ding-Ding Zhang has nothing to disclose.
Ajay Rajshekar, DO	Dr. Rajshekar has nothing to disclose.
Claudia Cruzalegui Bazán	Miss Cruzalegui Bazán has nothing to disclose.
Nur Neyal, MD	Dr. Neyal has nothing to disclose.
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Jun Ni	Jun Ni has nothing to disclose.
Garrett M. Friedman, MD	Dr. Friedman has nothing to disclose.
Anand V. Patel, MD	Dr. Patel has nothing to disclose.
Claudia M. Prospero Ponce, MD	Dr. Prospero Ponce has nothing to disclose.
Federico Casale	No disclosure on file
Michael Grunstein, DO	Dr. Grunstein has nothing to disclose.
Bonnie E. Levin, PhD	No disclosure on file
Muhammad Z. Memon, MD	Dr. Memon has nothing to disclose.
Amira Salim	Miss Salim has nothing to disclose.
Walter G. Husar, MD	Dr. Husar has nothing to disclose.
Anuja R. Patil, MD, DM	Dr. Patil has nothing to disclose.
Vikram Prakash, MD	Dr. Prakash has nothing to disclose.
Amanda Persaud, MD	Dr. Persaud has nothing to disclose.
Darshini Shah, Other	Ms. Shah has received personal compensation for serving as an employee of AbbVie. Ms. Shah has stock in AbbVie Inc. An immediate family member of Ms. Shah has received research support from National Institutes of Health.
Joshua Nahm	No disclosure on file
Doug Gunzler	No disclosure on file
Ayah Al-Bzour	Miss Al-Bzour has nothing to disclose.
Nevin A. John, MBBS	Dr. John has nothing to disclose.
Andrea Pardo, MD	The institution of Dr. Pardo has received research support from UCB Biosciences. The institution of Dr. Pardo has received research support from The Patrick G. and Shirley W. Ryan Foundation . The institution of Dr. Pardo has received research support from NINDS- Stroke Trials Network. The institution of Dr. Pardo has received research support from NINDS-I-ACQUIRE. The institution of Dr. Pardo has received research support from NINDS- VIPS-II.
Grace Gombolay, MD, FAAN	The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Hashem Shaltoni, MD	Dr. Shaltoni has nothing to disclose.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Yorghos Tripodis	Yorghos Tripodis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association.
Ankit Pahwa	Ankit Pahwa has nothing to disclose.
Michael D. Weiss, MD, FAAN	Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Peter C. Dowling, MD	No disclosure on file
Jiangyong Min, MD	Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Siegfried Hirczy, MD	An immediate family member of Dr. Hirczy has received personal compensation for serving as an employee of Meta. Dr. Hirczy has received personal compensation in the range of $500-$4,999 for serving as a Author with Slack Enterprises.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Russell D'Aiello	No disclosure on file
Jonadab Dos Santos Silva, MD, PhD	Dr. Dos Santos Silva has nothing to disclose.
Julia See	Miss See has nothing to disclose.
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Alexander Bolufer, MD	Mr. Bolufer has nothing to disclose.
Michael Kruer, MD	Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Rajeev Kumar, MD, FRCPC	The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to AAN interests or activities.
Natalia Bohorquez Morera	Natalia Bohorquez Morera has nothing to disclose.
Calvin Hu, MD	Dr. Hu has nothing to disclose.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Stephen Jaworski, MD	Dr. Jaworski has nothing to disclose.
Nathaniel J. Mohney, MD	The institution of Dr. Mohney has received research support from NIH.
Scott Husak	Scott Husak has nothing to disclose.
Maurice Driessen	No disclosure on file
Wim Noel	Mr. Noel has nothing to disclose.
Lyubov Rubin, MD	Dr. Rubin has nothing to disclose.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Rana Hanna AL-Shaikh, MD	Dr. Hanna AL-Shaikh has nothing to disclose.
Jamie N. Lehnen, MD	Ms. Lehnen has nothing to disclose.
Jenny Meyer, MD	The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Carmen Vizzino	No disclosure on file
Ammar I. Hamza, MD	Mr. Hamza has nothing to disclose.
Thomas E. Ragole, MD	The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. The institution of Dr. Ragole has received research support from Alexion Pharmaceuticals.
Tritia R. Yamasaki, MD, PhD, FAAN	The institution of Dr. Yamasaki has received research support from Veteran's Affairs. The institution of an immediate family member of Dr. Yamasaki has received research support from Dept of Energy.
Melanie Boly, MD	Dr. Boly has nothing to disclose.
Steven Tyler	No disclosure on file
Niki Holtzman-Hayes, MD	Dr. Holtzman-Hayes has nothing to disclose.
Ahmed A. Bayoumi, MD	Dr. Bayoumi has nothing to disclose.
Amy Lavery	No disclosure on file
Connie H. Yan, PhD, PharmD	Dr. Yan has received personal compensation for serving as an employee of AbbVie Inc. Dr. Yan has stock in AbbVie Inc.
Steven A. Gunzler, MD, FAAN	Dr. Gunzler has received research support from NIH/NINDS. Dr. Gunzler has received research support from Parkinson's Foundation. The institution of Dr. Gunzler has received research support from UCB. The institution of Dr. Gunzler has received research support from Bial.
Brian M. Sauer, MD	The institution of Dr. Sauer has received research support from Annexon, Inc.. The institution of Dr. Sauer has received research support from Patient Centered Outcomes Research Center via Mayo Clinic. The institution of Dr. Sauer has received research support from Argenx. The institution of Dr. Sauer has received research support from NINDS & Amgen, Inc.. The institution of Dr. Sauer has received research support from Bristol Myers Squibb; Janssen Pharmaceutical Companies of Johnson & Johnson. The institution of Dr. Sauer has received research support from Hoffmann-La Roche. The institution of Dr. Sauer has received research support from UCB Biopharma SRL. Dr. Sauer has a non-compensated relationship as a Advisory Board Member, Neuroscience Advisor with Donor Alliance, Inc. that is relevant to AAN interests or activities.
Lisa Christopher-Stine, MD, MPH	No disclosure on file
Juliana Nitis	Ms. Nitis has nothing to disclose.
Carlos Rodrigo Q. Vicuña	Mr. Vicuña has nothing to disclose.
Irene Dixe de Oliveira Santo, MD	Dr. Dixe de Oliveira Santo has nothing to disclose.
Hannah M. Bullock	Ms. Bullock has nothing to disclose.
Erika Shelton	No disclosure on file
Fardin Nabizadeh III	Mr. Nabizadeh has nothing to disclose.
Dawn L. Gano, MD	The institution of Dr. Gano has received research support from Cerebral Palsy Alliance Research Foundation. The institution of Dr. Gano has received research support from NIH.
Jaroslaw Dulski, MD, PhD	Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange. Dr. Dulski has received intellectual property interests from a discovery or technology relating to health care.
Meagen M. Salinas, MD	The institution of Dr. Salinas has received research support from North Texas VA Health Care System New Investigator Award.
Yaacov Anziska, MD	Dr. Anziska has nothing to disclose.
Emanuele Koumantakis	No disclosure on file
Mariam Aboian, MD, PhD	Dr. Aboian has a non-compensated relationship as a Principal Investigator with Visage Imaging that is relevant to AAN interests or activities.
Rebekah M. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Luiza Lima, MD	Dr. Lima has nothing to disclose.
Esther H. Nie, PhD	Dr. Nie has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Nie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medidata, Acorn AI. The institution of Dr. Nie has received research support from Roche/Genentech.
Henrik Ehrhardt, MBBCh	Henrik Ehrhardt has nothing to disclose.
Klepper Alfredo Garcia, MD	Dr. Garcia has nothing to disclose.
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
Yaman Ahmed	Mr. Ahmed has nothing to disclose.
Neeharika Thottempudi, MD	Dr. Thottempudi has nothing to disclose.
Joseph Y. Yoon, MD	Dr. Yoon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ECHAS.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Jesse B. Mez, MD	The institution of Dr. Mez has received research support from NIH, DOD.
Yilun Chen	Ms. Chen has nothing to disclose.
Sindhu Ramchandren, MD	Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Benjamin Malinda	Mr. Malinda has nothing to disclose.
Jennifer Bain, MD, PhD	Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. The institution of Dr. Bain has received research support from Yellow Brick Road Project.
Jairo A. Gaitan Alfonso, MD	Dr. Gaitan Alfonso has nothing to disclose.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Laura A. Adang, MD	Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Junpeng Zhuang	Dr. Zhuang has received personal compensation for serving as an employee of Eli Lilly.
Sahil Kapoor	No disclosure on file
Runi Tanna, MD	Miss Tanna has nothing to disclose.
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Elizabeth G. Baumann, MD	Dr. Baumann has nothing to disclose.
Yvonne Hao	Miss Hao has nothing to disclose.
Judy Van De Water	Judy Van De Water has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MARAbio. Judy Van De Water has stock in MARAbio. Judy Van De Water has received intellectual property interests from a discovery or technology relating to health care.
Michael A. Connerney, MD	Dr. Connerney has nothing to disclose.
Scott Harcourt, PhD	Dr. Harcourt has nothing to disclose.
Giulia S. Porcari, MD	The institution of Dr. Porcari has received research support from NIH/NINDS (T32 - NS-061779).
Patrick M. Kwon, MD	Dr. Kwon has nothing to disclose.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Inna Keselman, MD, PhD	Dr. Keselman has nothing to disclose.
Michelle Fullard, MD	Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Jessalyn Shen, MD	Dr. Shen has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Seema Soni-Brahmbhatt	Seema Soni-Brahmbhatt has nothing to disclose.
Lars Viktrup	No disclosure on file
Tatiana Greige, MD	Dr. Greige has nothing to disclose.
Manan Shah, MD, MBBS	Dr. Shah has nothing to disclose.
Carlton Anderson, PhD	Mr. Anderson has nothing to disclose.
Nicholas Lannen, MD	Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Jeffrey E. Dunn, MD, FAAN	Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics. Dr. Dunn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna Therapeutics. Dr. Dunn has received intellectual property interests from a discovery or technology relating to health care.
Yamuna Joseph	No disclosure on file
Leah P. Dickstein, MD	Dr. Dickstein has nothing to disclose.
Grigorios Kalaitzidis, MD	Mr. Kalaitzidis has nothing to disclose.
Lucas Kipp, MD	The institution of Dr. Kipp has received research support from Genentech.
Mark S. Scher, MD	Dr. Scher has nothing to disclose.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Justin Kinsella, MD	Dr. Kinsella has nothing to disclose.
Anna Vasilevskaya, PhD	Anna Vasilevskaya has nothing to disclose.
Jeffrey Dage, PhD	Dr. Dage has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Dage has stock in Eli Lilly and Company. Dr. Dage has stock in General Electric. Dr. Dage has received research support from Indiana University School Of Medicine. Dr. Dage has received intellectual property interests from a discovery or technology relating to health care.
Adam Brickman, PhD	Adam Brickman, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cognito Therapeutics. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Illinois. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. Adam Brickman, PhD has stock in Tau Biosciences. Adam Brickman, PhD has stock in CogniScreen.
John Thomson, PhD	Dr. Thomson has received personal compensation for serving as an employee of Wren Therapeutics. Dr. Thomson has received intellectual property interests from a discovery or technology relating to health care. Dr. Thomson has received intellectual property interests from a discovery or technology relating to health care.
Ajay Garg	Ajay Garg has nothing to disclose.
Jonathan Rosenthal, MD	Dr. Rosenthal has nothing to disclose.
Lauren Nelson, MD	Dr. Nelson has nothing to disclose.
Yingyi Liu	Yingyi Liu has received personal compensation for serving as an employee of AbbVie.
Tae Jin Park	Mr. Park has received personal compensation for serving as an employee of AbbVie. Mr. Park has stock in AbbVie.
Bryan Cobb, PhD, FACMGG	Dr. Cobb has received personal compensation for serving as an employee of Genentech. Dr. Cobb has stock in Roche. Dr. Cobb has received intellectual property interests from a discovery or technology relating to health care.
Prasanna Kumar Gangishetti, MBBS	Dr. Gangishetti has nothing to disclose.
Oralee J. Varnado, PhD	Miss Varnado has received personal compensation for serving as an employee of Eli Lilly and Company. Miss Varnado has stock in Eli Lilly and Company.
Chloe Anastassiadis	Ms. Anastassiadis has received research support from Fonds de Recherche du Québec - Santé (FRQS).
Hiba Naveed, MD	Ms. Naveed has nothing to disclose.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Sylvia Josephy, MD	Dr. Josephy has nothing to disclose.
Gabriel Rodriguez	Gabriel Rodriguez has nothing to disclose.
Caroline Goldin, MD	Dr. Goldin has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Aybuke Acar, MD	Dr. Acar has nothing to disclose.
Nour N. Al-Bzour	Miss Al-Bzour has nothing to disclose.
Ahmed Harazeen, MD	Dr. Harazeen has nothing to disclose.
Hirokazu Fujiwara	No disclosure on file
Rohit Aggarwal, MD	Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Eduardo Inacio Nascimento Andrade, MD	Dr. Nascimento Andrade has nothing to disclose.
Arie Gafson, MD, PhD	Dr. Gafson has stock in Biogen.
Zabeen K. Mahuwala, MD, FAAN	Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Benedetta Nacmias	Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Paul V. Motika, MD	Dr. Motika has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Andrew M. Nguyen, MD	Dr. Nguyen has nothing to disclose.
Melanie Manning	Melanie Manning has nothing to disclose.
Siddharth Dalal, MD	Dr. Dalal has nothing to disclose.
Jin Nakahara, MD, PhD, FAAN	Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science.
Monica Lemmon, MD	Dr. Lemmon has received research support from NINDS. Dr. Lemmon has received research support from BAND foundation. Dr. Lemmon has received research support from Doris Duke Charitable Foundation. Dr. Lemmon has received research support from Child Neurology Society.
Emily Sergio, Other	Ms. Sergio has nothing to disclose.
Ivanna Joseph, MD	Dr. Joseph has nothing to disclose.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Vanessa Salej, MD	Dr. Salej has nothing to disclose.
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Vanessa C. Colares Lessa, MD	Dr. Colares Lessa has nothing to disclose.
Lawrence S. Honig, MD, PhD, FAAN	Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Gabriel R. Arismendi, MD	Dr. Arismendi has nothing to disclose.
Christopher Lock, MD, MBBS, PhD	Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Turning Point Litigation. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann, LLP. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McQuaide Blasko Attorneys at Law. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for BENNETT BIGELOW & LEEDOM P.S. .
Bert B. Vargas, MD, FAAN	Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Alexandra Seide Cardoso, MD	Dr. Seide Cardoso has nothing to disclose.
Daniel Kaganovich	Daniel Kaganovich has received personal compensation for serving as an employee of Wren Therapeutics.
Camelia Valhuerdi Porto, MD	Dr. Valhuerdi Porto has nothing to disclose.
Jerry Chen, MD	Dr. Chen has nothing to disclose.
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Ann C. McKee, MD	Dr. McKee has nothing to disclose.
Nancy Song, MD	Dr. Song has nothing to disclose.
Anisha Patel, PhD	Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
Julia R. Schneider, DO	Dr. Schneider has nothing to disclose.
Elena Monai, MD	Dr. Monai has nothing to disclose.
Michelle D. DeJesus Brazitis, MD	Dr. DeJesus Brazitis has nothing to disclose.
Emily Zivin	No disclosure on file
Maya Pandit, MD	Ms. Pandit has nothing to disclose.
Ling Ling Rong, MD	Dr. Rong has nothing to disclose.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
Sindhura Tadisetty	Mrs. Tadisetty has nothing to disclose.
Allison R. Valerius, MD	Dr. Valerius has nothing to disclose.
Hassnain A. Rizvi, DO	Dr. Rizvi has nothing to disclose.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Yun-Beom Choi, MD, PhD	The institution of Dr. Choi has received research support from Department of Veterans Affairs.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Jorge Zamudio, MD, MBA	Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Carolina Parker, MD	Dr. Parker has nothing to disclose.
Gustavo Schafascheck, MD	Dr. Schafascheck has nothing to disclose.
Taylor R. Anderson, MD	Dr. Anderson has nothing to disclose.
Alex Berger, BS	Mr. Berger has nothing to disclose.
Stephane Regnier, PhD	Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.
Ashley Dafoe	No disclosure on file
Neda Sattarnezhad Oskouei, MD	Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Koji Sekiguchi	No disclosure on file
Julia Sumera	Miss Sumera has nothing to disclose.
Stefano Magon	Stefano Magon has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.. Stefano Magon has stock in F. Hoffmann-La Roche Ltd..
Zaza Katsarava, MD	Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Jeremy S. Chataway, MD	Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Matteo Locatelli, BS	Mr. Locatelli has nothing to disclose.
Sean T. Kenniff, MD	Dr. Kenniff has nothing to disclose.
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Nilufer Yalcin, MD	Dr. Yalcin has nothing to disclose.
Justine Shults	No disclosure on file
Richard P. Mayeux, MD, MSc, FAAN	Dr. Mayeux has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Robert A. Nicholson, PhD	Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Schott, MD, FRCP, FEAN, FAAN	Dr. Schott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alzheimer's Research UK. Dr. Schott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UK Dementia Research Institute. Dr. Schott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Schott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE. Dr. Schott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press.
Walter Faig	Walter Faig has received personal compensation for serving as an employee of Westat.
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Joon-Shik Moon, MD	Dr. Moon has nothing to disclose.
Chetan Nayak, MD, PhD	Dr. Nayak has nothing to disclose.
Julie A. Gurwell, PhD, PA-C	Dr. Gurwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Gurwell has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� . The institution of Dr. Gurwell has received research support from University of Kentucky Brain Restoration Center. The institution of Dr. Gurwell has received research support from University of Kentucky Department of Neurology Pilot Grant. Dr. Gurwell has received personal compensation in the range of $500-$4,999 for serving as a speaker at the annual CME meeting with Kentucky Academy of Physician Assistants.
Ivonne Suridjan	No disclosure on file
Jay-Jiguang Zhu, MD, PhD, FAAN	The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Priyanka Moondra, DO	Dr. Moondra has nothing to disclose.
William Avery	William Avery has stock in Nuvig Therapeutics.
Ulrike Bonati	Ulrike Bonati has received personal compensation for serving as an employee of Hoffman-La Roche. An immediate family member of Ulrike Bonati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InnoHeart. The institution of an immediate family member of Ulrike Bonati has received research support from Astra Zeneca . The institution of an immediate family member of Ulrike Bonati has received research support from Bayer. The institution of an immediate family member of Ulrike Bonati has received research support from Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss Heart Foundation. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss National Science Foundation.
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Rajesh Kumar Singh	Rajesh Kumar Singh has nothing to disclose.
Haruhiko Motegi, MD	Dr. Motegi has nothing to disclose.
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Megan Morris	No disclosure on file
Klevest Gjini	Klevest Gjini has nothing to disclose.
Damiano Mistri, MSC	Mr. Mistri has nothing to disclose.
Sandro Sorbi	Sandro Sorbi has nothing to disclose.
Howard W. Sander, MD, FAAN	Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Charles L. Wade, MBBS	Dr. Wade has nothing to disclose.
Yasamin Mahjoub, MD	Dr. Mahjoub has nothing to disclose.
Maryann Mays, MD, FAAN	Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Milagros D. Pascual-Guevara	Miss Pascual-Guevara has nothing to disclose.
Vishakhadatta Mathur Kumaraswamy, MD	The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Arun S. Chhabra, MD	Dr. Chhabra has stock in Pfizer. Dr. Chhabra has stock in Biogen. Dr. Chhabra has stock in Johnson and Johnson. Dr. Chhabra has stock in Medtronic.
David S. Lynch, MBBS, PhD	Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis.
Emily White, MD	Dr. White has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Robert Stern, PhD	Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Briana Cameron, PhD	Dr. Cameron has received personal compensation for serving as an employee of Genentech. Dr. Cameron has stock in Genentech.
Taha Qarni, MD	Dr. Qarni has nothing to disclose.
Amulya Gottiparthy, MD	Dr. Gottiparthy has nothing to disclose.
Robert E. Hogan, MD	Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
Elsa Salim Karam, MD	Dr. Salim Karam has nothing to disclose.
Shan E. Abbas, MD	Dr. Abbas has nothing to disclose.
Maria J. Bruzzone, MD, FAAN	Dr. Bruzzone has nothing to disclose.
Mohsen Ahmed	Mr. Ahmed has nothing to disclose.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Elise R. Hennessy, MD	Dr. Hennessy has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS	Dr. Pasya has nothing to disclose.
Tyler Kendall, MD	Dr. Kendall has nothing to disclose.
Laura Hayse, MD	Ms. Hayse has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Bruno Giometto, MD	Dr. Giometto has nothing to disclose.
Jamie Wong, PhD	Dr. Wong has nothing to disclose.
Audrey Strongosky	No disclosure on file
Rohan B. Yarlagadda, DO	Mr. Yarlagadda has nothing to disclose.
Josefina Maranzano	The institution of Ms. Maranzano has received research support from Natural Sciences and Engineering Research Council of Canada.
Marcos Santana Firme, MD	Dr. Santana Firme has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Giuseppe Fuda	No disclosure on file
Jasmin Patel, MD	Dr. Patel has nothing to disclose.
Faiza Ahmed, MD	No disclosure on file
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Vera Pertsovskaya, MD	Miss Pertsovskaya has nothing to disclose.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Arunmozhimaran Elavarasi, MD	Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Kathleen B. Mullin, MD	Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Allahshukur Ilgarli, MD	Dr. Ilgarli has nothing to disclose.
Henry Houlden	No disclosure on file
Jared C. Wolfe, MD	Dr. Wolfe has nothing to disclose.
Melissa A. Wright, MD	Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
David B. Kudrow, MD	Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Annelly Buré-Reyes	Annelly Buré-Reyes has nothing to disclose.
Anthony P. Zampino, MD	Dr. Zampino has nothing to disclose.
Charulata N. Venkatesan, MD, PhD	Dr. Venkatesan has nothing to disclose.
Mehdi Ghasemi, MD	Dr. Ghasemi has nothing to disclose.
Maurice Vincent, MD, PhD	Prof. Vincent has received personal compensation for serving as an employee of Eli Lilly and Company. Prof. Vincent has stock in Eli Lilly and Company.
Nicanor Mori, MD	Dr. Mori has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Serena S. Hoost, MD	Ms. Hoost has nothing to disclose.
Eleni Vasileiou, MD	Dr. Vasileiou has nothing to disclose.
Garima Shukla, MD, MBBS, DM, FRCPC	The institution of Prof. Shukla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Adithya Sivaraju, MD	Dr. Sivaraju has nothing to disclose.
Sydney M. Shaffer, MD	Dr. Shaffer has nothing to disclose.
Kelvin K. Chang	Mr. Chang has nothing to disclose.
Peter P. Pacut, MD	Dr. Pacut has nothing to disclose.
Miguel F. Cabanillas Lazo	Mr. Cabanillas Lazo has nothing to disclose.
Bastien C. Caba	Mr. Caba has received personal compensation for serving as an employee of Therapanacea. Mr. Caba has received personal compensation for serving as an employee of Biogen. Mr. Caba has received personal compensation in the range of $50,000-$99,999 for serving as a Research Engineer with Therapanacea. Mr. Caba has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist II, ML/AI with Biogen.
Saul Reyes, MD	Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Aya N. Shnawa, MD	Dr. Shnawa has nothing to disclose.
Clover Youn, MD	Dr. Youn has nothing to disclose.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Zhuoran Yao	Mr. Yao has nothing to disclose.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Shayan Marsia, MBBS	Dr. Marsia has nothing to disclose.
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Andrew Russo	Andrew Russo has nothing to disclose.
John A. Lincoln, MD, PhD	The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
Matteo Albergoni, PT	Dr. Albergoni has nothing to disclose.
Michael Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroAlert. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Rizamarie Empeno, MD	Dr. Empeno has nothing to disclose.
Yian Gu, PhD	The institution of Dr. Gu has received research support from NIH.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Francesco Gavazzi, MD, MD, PhD	The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
Dylan F. Del Papa, MD	Dr. Del Papa has nothing to disclose.
Steven Peters, MD	Dr. Peters has nothing to disclose.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Saniya Pervin, MD	Dr. Pervin has nothing to disclose.
Ruaa Ibrahim	Ms. Ibrahim has nothing to disclose.
Yohannes S. Mulatu, MD	Dr. Mulatu has nothing to disclose.
Umair Azhar	Mr. Azhar has nothing to disclose.
Miranda Flamholz	Miss Flamholz has nothing to disclose.
Mayra Montalvo Perero, MD	Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Lisa Scott, MD, DO	Dr. Scott has nothing to disclose.
Daniela S. Rodriguez	Ms. Rodriguez has nothing to disclose.
Rose P. Griffin	Ms. Griffin has nothing to disclose.
Sania Azhar	Ms. Azhar has nothing to disclose.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Rosa De Abreu Ferreira	Rosa De Abreu Ferreira has nothing to disclose.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Jessie A. Walker, MD	Dr. Walker has nothing to disclose.
Anabel Marre, Other	An immediate family member of Ms. Marre has received personal compensation for serving as an employee of EMD Serono, Inc.. An immediate family member of Ms. Marre has received personal compensation for serving as an employee of MFS Investment Management. Ms. Marre has received research support from Office of Undergraduate Research which is administered by Northwestern University's Office of the Provost.
Jeff Gao, MD	No disclosure on file
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Saad	Dr. Saad has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Pooja Venkatesh	Miss Venkatesh has nothing to disclose.
Amal Abbes	Ms. Abbes has nothing to disclose.
Victor Fung, MD, MBBS, PhD	Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Carmela Tartaglia, MD	Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Susan Hutchinson	Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Despoina Ioannidou, PhD	Dr. Ioannidou has received personal compensation for serving as an employee of Therapanacea.
Mohammad Ghatali, MD	Dr. Ghatali has nothing to disclose.
Laura A. Stein, MD	Dr. Stein has nothing to disclose.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Ryan Emmanuel, MD	Mr. Emmanuel has nothing to disclose.
Rodrigo Gaudio	No disclosure on file
Farren Briggs, PhD	The institution of Prof. Briggs has received research support from NIH.
Jennifer Adrissi, MD	Dr. Adrissi has nothing to disclose.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Giovanni R. Malaty, MD	Dr. Malaty has nothing to disclose.
Neel Fotedar, MD	Dr. Fotedar has received research support from NINDS.
Federica Boso	Federica Boso has nothing to disclose.
Arman Cakar	Arman Cakar has nothing to disclose.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Elias S. Sotirchos, MD	Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dragos Manta	Dragos Manta has nothing to disclose.
Ziad Alahmad	Dr. Alahmad has nothing to disclose.
Danielle G. Barber, MD, PhD	The institution of Dr. Barber has received research support from NIH.
Yazan S. Al-Zamer	Mr. Al-Zamer has nothing to disclose.
Drew S. Kern, MD, FAAN	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Lindsay Tetreault, MD, PhD	Dr. Tetreault has nothing to disclose.
Omar Jbarah	Omar Jbarah has nothing to disclose.
Leona Ling, PhD	Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Jason S. Gill, MD, PhD	Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Fatemeh Seifar	Ms. Seifar has nothing to disclose.
Tejas Patel	No disclosure on file
John Furey	Mr. Furey has nothing to disclose.
Philion Gatchoff, MD	Dr. Gatchoff has nothing to disclose.
Jessica Feistel, DO	Dr. Feistel has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Francesca Palumbo	No disclosure on file
Maurizio Grassano, MD	Dr. Grassano has received research support from American Brain Foundation, ALS Association and ��ɫ��.
Chilvana V. Patel, MBBS, FAAN	Dr. Patel has nothing to disclose.
Birendra Sah	Birendra Sah has received publishing royalties from a publication relating to health care.
Ton Fang, MBBS	Dr. Fang has nothing to disclose.
Andrea Mendez Colmenares, MD, PhD	Dr. Mendez Colmenares has nothing to disclose.
Samah K. Aburahma, MD	Dr. Aburahma has nothing to disclose.
Sydnie Jones, MD	Dr. Jones has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Linda Mosher	No disclosure on file
David Clayton	David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
Patrick Hecht, PhD	Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Jarrett Leech, MD	Dr. Leech has nothing to disclose.
Bhavya Narapureddy, MBBS	Dr. Narapureddy has nothing to disclose.
Stefan Gillen, DO	Dr. Gillen has nothing to disclose.
Ketevan Amirkhanashvili, MD	Dr. Amirkhanashvili has nothing to disclose.
Hongxuyang Yu, MD	Dr. Yu has nothing to disclose.
Karen Williams	Karen Williams has nothing to disclose.
Jerry Hall	Jerry Hall has received personal compensation for serving as an employee of Eli Lilly & Co.. Jerry Hall has stock in Eli Lilly & Co..
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Jamie C. McDonald, MD	Dr. McDonald has nothing to disclose.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Gabriel I. Cassinelli Petersen	Mr. Cassinelli Petersen has nothing to disclose.
Joshua Joung, Other	Mr. Joung has nothing to disclose.
Elizabeth Fisher	Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Jorge L. Rodriguez Lee, MD	Dr. Rodriguez Lee has nothing to disclose.
Stefano Callegaro	No disclosure on file
Benjamin Chapin, MD	Dr. Chapin has nothing to disclose.
Jason Weller, MD	Dr. Weller has nothing to disclose.
Paolina Salamone	No disclosure on file
Carolina B. Moura, MD	Dr. Moura has nothing to disclose.
Susie Y. Huang, MD, PhD	Dr. Huang has received personal compensation in the range of $0-$499 for serving as a Consultant for Siemens Healthineers. The institution of Dr. Huang has received research support from Siemens Healthineers. The institution of Dr. Huang has received research support from Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School.
Margaret Hoyt, PhD	Dr. Hoyt has received personal compensation for serving as an employee of Eli Lilly and Co.. Dr. Hoyt has stock in Eli Lilly and Co..
Foad Taghdiri, MD, MSc	Dr. Taghdiri has nothing to disclose.
Kathryn Gallison, Other	The institution of Miss Gallison has received research support from Ionis Pharmaceuticals.
Eva Angela Krijnen	Ms. Krijnen has nothing to disclose.
Dimitrios Kapogiannis, MD	The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Gary D. Berman, MD	Dr. Berman has received personal compensation for serving as an employee of Clinical Research Institute. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Derek Neilson	Derek Neilson has nothing to disclose.
Srinivas Medavarapu, MD, MBBS	Dr. Medavarapu has nothing to disclose.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Jenifer Cordon	Miss Cordon has nothing to disclose.
Emily Spoth	Emily Spoth has nothing to disclose.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Kenji Kufukihara, MD	Dr. Kufukihara has nothing to disclose.
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Aine P. Merwick, MD	The institution of Dr. Merwick has received research support from Irish Institute of Clinical Neuroscience.
Benjamin J. Puccio, MD	Dr. Puccio has nothing to disclose.
Danurys Sanchez	Danurys Sanchez has nothing to disclose.
Laura Gaetano	Laura Gaetano has received personal compensation for serving as an employee of Roche. Laura Gaetano has received stock or an ownership interest from Roche.
Ethar Hazaimeh, MD	Dr. Hazaimeh has nothing to disclose.
Muhammed Ors	Mr. Ors has nothing to disclose.
Danielle Larson, MD	Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Jennifer J. Manly, PhD	The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
David F. Tang-Wai, MD, FRCPC	Dr. Tang-Wai has nothing to disclose.
Meghana Karnik-Henry, PhD	Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
Badria Munir, MD	Dr. Munir has nothing to disclose.
Mangayarkarasi Thandampallayam Ajjeya, MBBS	Dr. Thandampallayam Ajjeya has nothing to disclose.
Estevao P. Ribeiro, MD	Dr. Ribeiro has nothing to disclose.
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Faiza Ahmed	Ms. Ahmed has nothing to disclose.
Cecilia Quarracino Benchetrit, MD	Mrs. Quarracino Benchetrit has nothing to disclose.
Ronel Santos	No disclosure on file
Phoebe Jiang, PhD	Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Mario Ortega, PhD	Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Abigail S. Bose, MD	Dr. Bose has nothing to disclose.
Vivien Ikwuazom	Vivien Ikwuazom has nothing to disclose.
Jorge E. Patino Murillas, MD	Dr. Patino Murillas has nothing to disclose.
Sarah Levy, PhD	Dr. Levy has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��